Analysis of the INK4a/ARF locus in non-Hodgkin's lymphomas using two new internal microsatellite markers

被引:17
作者
Herranz, M
Urioste, M
Santos, J
Rivas, C
Martínez, B
Benitez, J
Fernández-Piqueras, J [1 ]
机构
[1] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, Lab Genet Mol Humana, E-28049 Madrid, Spain
[2] Fdn Jimenez Diaz, Dept Genet, E-28040 Madrid, Spain
[3] Fdn Jimenez Diaz, Dept Genet, E-28040 Madrid, Spain
[4] Fdn Jimenez Diaz, Dept Patol, E-28040 Madrid, Spain
关键词
INK4a/ARF locus; internal microsatellites; NHLs; LOH; genetic instability;
D O I
10.1038/sj.leu.2401409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inactivation of the INK4a/ARF locus is a frequent event in non-Hodgkin's lymphomas (NHLs), which may be attributed to deletion, point mutation, and 5' CpG methylation at its promoter region. In the present study we evaluated the occurrence of deletions and genetic instability of INK4a/ARF locus in 30 paired normal and tumor samples of B cell NHLs by conducting an allelotypic analysis with two new polymorphic markers, one located at the intron 1 of p16(INK4a) gene and the other one placed downstream exon 1 beta of p19(ARF). Comparison of these results with those obtained in a previous paper using flanking markers (D9S171, D9S942, D9S956 and IFNA) allowed us to detect two new cases of microsatellite instability (L-446 and L-442), and to confirm the occurrence of LOH at the INK4a/ARF locus in one tumor (M-3770). On the contrary, this locus is not affected in three different tumors (L-421, L-272 and L-159) which exhibited LOH at some of the flanking markers.
引用
收藏
页码:808 / 810
页数:3
相关论文
共 12 条
[1]  
CHAUVERT P, 1997, MOL CELL PROBE, V10, P467
[2]   The human protein p19(ARF) is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16(INK4a)/MTS1 gene [J].
DellaValle, V ;
Duro, D ;
Bernard, O ;
Larsen, CJ .
ONCOGENE, 1997, 15 (20) :2475-2481
[3]   Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage [J].
FernandezPiqueras, J ;
Santos, J ;
Perez de Castro, I ;
Melendez, B ;
Martinez, B ;
Robledo, M ;
Rivas, C ;
Benitez, J .
CANCER GENETICS AND CYTOGENETICS, 1997, 98 (01) :63-68
[4]   Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia [J].
Gardie, B ;
Cayuela, JM ;
Martini, S ;
Sigaux, F .
BLOOD, 1998, 91 (03) :1016-1020
[5]   Potential role for concurrent abnormalities of the cyclin D1, p16(CDKN2) and p15(CDKN2B) genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519) [J].
Jadayel, DM ;
Lukas, J ;
Nacheva, E ;
Bartkova, J ;
Stranks, G ;
DeSchouwer, PJJC ;
Lens, D ;
Bartek, J ;
Dyer, MJS ;
Kruger, AR ;
Catovsky, D .
LEUKEMIA, 1997, 11 (01) :64-72
[6]  
MAO L, 1995, CANCER RES, V55, P2995
[7]  
MartinezDelgado B, 1997, AM J HEMATOL, V55, P1, DOI 10.1002/(SICI)1096-8652(199705)55:1<1::AID-AJH1>3.0.CO
[8]  
2-Y
[9]   Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma [J].
MartinezDelgado, B ;
FernandezPiqueras, J ;
Garcia, MJ ;
Arranz, E ;
Gallego, J ;
Rivas, C ;
Robledo, M ;
Benitez, J .
LEUKEMIA, 1997, 11 (03) :425-428
[10]   5' CPG ISLAND METHYLATION IS ASSOCIATED WITH TRANSCRIPTIONAL SILENCING OF THE TUMOR-SUPPRESSOR P16/CDKN2/MTS1 IN HUMAN CANCERS [J].
MERLO, A ;
HERMAN, JG ;
MAO, L ;
LEE, DJ ;
GABRIELSON, E ;
BURGER, PC ;
BAYLIN, SB ;
SIDRANSKY, D .
NATURE MEDICINE, 1995, 1 (07) :686-692